Conference will also be streamed virtually

Register Today

Friends of Cancer Research (Friends) and the Parker Institute for Cancer Immunotherapy (PICI) are proud to announce our upcoming joint public meeting, Unlocking Next-Generation Therapies: Exploring Innovative Development and Manufacturing Models for CAR T-Cell Therapies. CAR T-cell therapies have demonstrated remarkable success in treating certain cancers and offer a potential model for other complex biological therapies. However, these personalized therapies face significant barriers in timeliness, accessibility, and affordability within traditional, centralized manufacturing systems. Friends is launching a new multi-stakeholder working group to develop a practical framework for decentralized manufacturing and flexible production of CAR T-cell therapies. By examining the regulatory, safety, and operational considerations, this initiative seeks to support patient-centered approaches to cell therapy development while upholding high standards of quality and safety. Ultimately, this could help facilitate faster, more affordable, and more accessible CAR T-cell therapies for patients. Check back for more details.